Alina Iuga
Overview
Explore the profile of Alina Iuga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
1102
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fu J, Hsiao T, Waffarn E, Meng W, Long K, Frangaj K, et al.
Front Immunol
. 2024 Jul;
15:1375486.
PMID: 39007142
Introduction: It is unknown how intestinal B cell populations and B cell receptor (BCR) repertoires are established and maintained over time in humans. Following intestinal transplantation (ITx), surveillance ileal mucosal...
2.
Raufi A, Pellicciotta I, Palermo C, Sastra S, Chen A, Alouani E, et al.
bioRxiv
. 2024 Jan;
PMID: 38234792
Purpose: The CXCL12-CXCR4 chemokine axis plays a significant role in modulating T-cell infiltration into the pancreatic tumor microenvironment. Despite promising preclinical findings, clinical trials combining inhibitors of CXCR4 (AMD3100/BL-8040) and...
3.
Plasticity of intragraft alloreactive T cell clones in human gut correlates with transplant outcomes
Fu J, Wang Z, Martinez M, Obradovic A, Jiao W, Frangaj K, et al.
J Exp Med
. 2023 Dec;
221(1).
PMID: 38091025
The site of transition between tissue-resident memory (TRM) and circulating phenotypes of T cells is unknown. We integrated clonotype, alloreactivity, and gene expression profiles of graft-repopulating recipient T cells in...
4.
Fu J, Hsiao T, Waffarn E, Meng W, Long K, Frangaj K, et al.
medRxiv
. 2023 Nov;
PMID: 38014202
It is unknown how intestinal B cell populations and B cell receptor (BCR) repertoires are established and maintained over time in humans. Following intestinal transplantation (ITx), surveillance ileal mucosal biopsies...
5.
Dellon E, Peterson K, Mitlyng B, Iuga A, Bookhout C, Cortright L, et al.
Gut
. 2023 Jul;
72(10):1828-1837.
PMID: 37423717
Objective: We aimed to determine whether mepolizumab, an anti-IL-5 antibody, was more effective than placebo for improving dysphagia symptoms and decreasing oesophageal eosinophil counts in eosinophilic oesophagitis (EoE). Methods: We...
6.
Santhanam P, Iuga A, Sylvester F
JPGN Rep
. 2023 May;
3(4):e263.
PMID: 37168468
No abstract available.
7.
Obradovic A, Ager C, Turunen M, Nirschl T, Khosravi-Maharlooei M, Iuga A, et al.
Cancer Cell
. 2023 Apr;
41(5):933-949.e11.
PMID: 37116491
Due to their immunosuppressive role, tumor-infiltrating regulatory T cells (TI-Tregs) represent attractive immuno-oncology targets. Analysis of TI vs. peripheral Tregs (P-Tregs) from 36 patients, across four malignancies, identified 17 candidate...
8.
Thakkar K, Philpott H, LaFata S, Fowler M, Keene S, Iuga A, et al.
J Gastrointestin Liver Dis
. 2023 Apr;
32(1):15-22.
PMID: 37004219
Background And Aims: Some eosinophilic esophagitis (EoE) patients can have a decline in eosinophil count after proton pump inhibitor (PPI) treatment without achieving histologic response, but little is known about...
9.
Argmann C, Hou R, Ungaro R, Irizar H, Al-Taie Z, Huang R, et al.
Gut
. 2022 Sep;
72(7):1271-1287.
PMID: 36109152
Objective: IBD therapies and treatments are evolving to deeper levels of remission. Molecular measures of disease may augment current endpoints including the potential for less invasive assessments. Design: Transcriptome analysis...
10.
Parian A, Li L, Duraes L, Cheng J, Hu H, Yao Z, et al.
Dis Colon Rectum
. 2022 May;
66(3):425-433.
PMID: 35499985
Background: Perianal Crohn's disease is associated with poor outcomes and high medical costs. It is notoriously difficult to treat despite therapeutic advancements for luminal disease. A large animal model that...